Skip to content

Effect of ??Diclofenac rectal suppository in Pentazocin intake in pain after cesarean section in patients referred to Shahid Sadougi Hospital

Effect of ??Diclofenac rectal suppository in Pentazocin intake in pain after cesarean section in patients referred to Shahid Sadougi Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206176826N3
Enrollment
80
Registered
2012-07-13
Start date
2010-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post cesarean pain. Pelvic and perineal pain

Interventions

Intervention 1: Diclofenac Na rectal supp 50 , 100mg Aborayhan factory after cesarean section frist dose of Diclofenac Na rectal supp100mg and then 12,24, 36 hour after surgery Diclofenac Na rect
Treatment - Drugs
Diclofenac Na rectal supp 50 , 100mg Aborayhan factory after cesarean section frist dose of Diclofenac Na rectal supp100mg and then 12,24, 36 hour after surgery Diclofenac Na rectal supp50mg w
Pentazosin Amp (30mg) if necessary Tplidaro Factory

Sponsors

Shahid Sadougi University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-35 years old pregnant women; second or third time of cesarean section; single fetus and gestational age 37-42 week. Exclusion criterion: every complication during Anastasia and operation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain severity. Timepoint: 12, 24 and 36 hours and discharge time. Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Numder of amp pentasocine (30 mg) used. Timepoint: Till discharge time. Method of measurement: Number of amp.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshid Bokaie

Shahid Sadougi University of Medical Sciences

mah_bokaie@ssu.ac.ir+98 35 1824 1751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026